Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. - Wikidata - awgldk - TriplyDB

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q35532545

about

Inhaled corticosteroids for stable chronic obstructive pulmonary disease Inhaled corticosteroids for stable chronic obstructive pulmonary disease Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis Sputum myeloperoxidase in chronic obstructive pulmonary disease.Asthma versus chronic obstructive pulmonary disease--exploring why 'reversibility versus irreversibility' is no longer an appropriate approach.Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?Airways disease: phenotyping heterogeneity using measures of airway inflammation.The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.Factors influencing airway inflammation in chronic obstructive pulmonary disease.Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease.The link between chronic periodontitis and COPD: a common role for the neutrophil?Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease . 7: Management of COPD Airway inflammation contributes to health status in COPD: a cross-sectional study.Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.Sputum induction: review of literature and proposal for a protocol.Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma.Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release.A challenge to the seven widely believed concepts of COPD.Pharmacological treatment of chronic obstructive pulmonary disease.Salmeterol/fluticasone combination in the treatment of COPD.Eosinophilic airway inflammation in COPD Sputum analysis in diagnosis and management of obstructive airway diseases.Dysregulated apoptosis and NFkappaB expression in COPD subjects.Is there a role for antiinflammatory treatment in COPD?Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?Phenotyping the heterogeneity of chronic obstructive pulmonary disease.Critical assessment of the value of sputum neutrophils.A Sputum Proteomic Signature That Associates with Increased IL-1β Levels and Bacterial Exacerbations of COPD.Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.Long-term effects of budesonide on inflammatory status in COPD.Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.The effect of inhaled corticosteroids on the development of emphysema in smokers assessed by annual computed tomography.Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.Characterization of a population of small macrophages in induced sputum of patients with chronic obstructive pulmonary disease and healthy volunteers

P2860

Q24202092-4049EF6A-2D37-431A-9BBF-8EF4046CB436 Q24245481-2533CBF1-360A-43AF-AEB9-F17D472D8BC2 Q24797765-3C186F8E-5136-4E5B-8F3E-B5DE9679138C Q33592946-BA283A12-346A-4264-BAB6-FB0DF07ACA15 Q33640272-0B2492C6-2E1A-4BDF-A0AA-09DCBDBD7B9A Q33771465-3757990C-8A82-4AE2-BF40-EB1BD117A232 Q33771475-389FC235-6988-4A96-8168-0512A7AF4505 Q33864952-A648752B-58DB-4E3E-AC77-06DFA2D585AF Q33966009-7BF7BBF7-C871-4A6F-8E54-00D709A1CDFF Q34069584-E7ACA2E9-C911-42E5-8242-166E914BD633 Q34184746-AB31C57D-8FEE-4774-ABD4-2827D83BE318 Q34478144-B94FEF9D-57C9-467F-A2C7-93DA79C468D1 Q34760363-84095B3A-3BA9-41D8-85C8-C02744CF91A0 Q35075588-51DE188A-D1EE-4E65-B99F-4A2D7A4687D2 Q35220025-316C8529-B667-460C-9508-A7266DA13249 Q35534142-D64C4CD0-545E-473F-AC6D-EEB0E9E5B31D Q35537515-B423DFE6-CA1E-4903-9352-773BF10B8106 Q35604288-4DD0C82E-35A0-4422-913B-6B848BE72196 Q36145839-95639338-8010-4AA1-BCB3-EF4C09ECF93E Q36203159-97810FF7-B16A-47F2-9C1E-85E0AEDCC03D Q36558218-CA6A661B-3897-4DD7-82B9-24630140B37F Q37017344-58C8D090-72E6-4965-952B-FAFE284177DE Q37018817-99C868EB-8006-4E66-A189-F1800F2841C8 Q37018920-55194289-24B6-428A-99F7-48EECCC557D3 Q37116800-C089CCFB-CF14-45DB-A15B-FED65DCC833A Q37154063-B927768E-AE66-4576-9DD8-B409192D4420 Q37622935-870E3484-AF21-444B-9D90-ED38CD1F04DC Q37681569-C69537E0-5E97-4A29-A224-F333C440EBFC Q37839809-DCD797EE-9F0A-47A4-8665-E6A28142368B Q37951672-7D95362B-1353-4FD6-9150-79503D7A30A3 Q38063326-9B754754-E0A5-4219-BD4A-AC65137C71D0 Q38081909-B375CC97-E75A-4F96-8AE0-B7A6EABB4B8A Q40712644-67F31D30-96CC-4144-830C-363AE3A3BDBB Q44179168-A926B361-D030-4BAE-96C4-6CD0317FD40B Q44398976-B7CE2DBD-A23C-451F-8788-B01BE0D65734 Q44484408-CF30CAA1-E145-45C4-BEB9-C540C26F30C1 Q44960162-C4D82B00-8B41-4A6A-A18E-7E2672C7A769 Q46045096-782CE67B-BB0E-4211-81CD-1395C71F7390 Q46274712-FC49AF63-05D8-4E23-8272-656E1C81E564 Q56501445-25A1A637-D5D4-4FA9-8B9F-1D3DBD96868A

P2860

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q35532545

description

1998 nî lūn-bûn

@nan

1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@ast

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@en

type

label

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@ast

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@en

prefLabel

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@ast

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@en

P1433

Q35532545-838B8561-7E8B-4244-AB14-154E62081282

P1476

Q35532545-4896EEDD-D29D-4738-AAA4-457B25093CB1

P2093

Q35532545-0B8DCFAC-FD5E-479B-B9E0-5B1D4EF8E418

Q35532545-0DB5D7A8-165D-405F-9EEA-B9B0F8ED0CBD

Q35532545-448393AE-C796-457F-A096-D7B9EBC18B69

Q35532545-5031430E-E4EF-4ABC-8CF7-789C1F3D2A08

Q35532545-6E6ADC6D-D19B-4D53-B23B-7B1F9E025BB3

Q35532545-93AF904D-C98C-4957-BBCC-E89432503725

Q35532545-AD7FC516-75DE-426B-B90E-1E242889BBE8

P2860

Q35532545-357CAB34-D543-48CD-8075-23CC65FF6433

Q35532545-9EC494F3-EA8E-4FF0-BDFC-7D13BF6CB35C

Q35532545-F2914D37-259F-494A-A2B3-634E81E97863

P304

Q35532545-09ED1AD4-A695-4F01-8730-51FCB56C1DD7

P31

Q35532545-5FE6D85D-853A-4B37-A0FB-B1AE8C63D945

P356

Q35532545-844D0277-52A7-4860-B0EB-0FC59952D3C2

P407

Q35532545-2BC36FFD-5E63-45D8-AF37-752F39AC585A

P433

Q35532545-7B0C53FA-B630-44EC-A7F0-27C83956A3E8

P478

Q35532545-40E8C788-9141-4444-AB84-975C0AE5F01B

P577

Q35532545-E65F1DCB-2462-445D-9320-D682A2469801

P5875

Q35532545-3061127A-9A81-4B87-9CB4-75E12CB02F38

P698

Q35532545-627CC3D4-8CA7-42FC-A205-9331938FCE1F

P921

Q35532545-29D9B2CF-6942-469B-9553-0E190CA8FD93

Q35532545-BB56102C-3FD8-4663-8A77-316AF8E75FF2

P932

Q35532545-56C1455D-0E31-49E7-8EA0-AB4C4A0F5B83

P356

P1433

P1476

Inhaled corticosteroids reduce ...... obstructive pulmonary disease.

@en

P2093

Beghè B

http://www.w3.org/2001/XMLSchema#string

Bernorio S

http://www.w3.org/2001/XMLSchema#string

Confalonieri M

http://www.w3.org/2001/XMLSchema#string

Della Porta R

http://www.w3.org/2001/XMLSchema#string

Gandola L

http://www.w3.org/2001/XMLSchema#string

Mainardi E

http://www.w3.org/2001/XMLSchema#string

Spanevello A

http://www.w3.org/2001/XMLSchema#string

P2860

Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

The use of induced sputum to investigate airway inflammation.

P304

583-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.53.7.583

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13488230

http://www.w3.org/2001/XMLSchema#string

P698

9797758

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

1745263

http://www.w3.org/2001/XMLSchema#string